Caffeic acid phenethyl ester attenuates pro-inflammatory and fibrogenic phenotypes of LPS-stimulated hepatic stellate cells through the inhibition of NF-κB signaling

Zhao,Wen-Xing; Wang,Li; Yang,Ju-Lun; Li,Lian-Zhen; Xu,Wen-Mang; Li,Tao

doi:10.3892/ijmm.2013.1613

Caffeic acid phenethyl ester attenuates pro-inflammatory and fibrogenic phenotypes of LPS-stimulated hepatic stellate cells through the inhibition of NF-κB signaling

Authors:
- Wen-Xing Zhao
- Li Wang
- Ju-Lun Yang
- Lian-Zhen Li
- Wen-Mang Xu
- Tao Li
View Affiliations

Affiliations: Department of Pathology, Kunming General Hospital of PLA, Kunming, Yunnan 650032, P.R. China, School of Life Sciences of Yunnan University, Kunming, Yunnan 650091, P.R. China
Published online on: December 30, 2013 https://doi.org/10.3892/ijmm.2013.1613
Pages: 687-694

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatic stellate cells (HSCs) are the major cell type involved in liver fibrosis. Lipopolysaccharide (LPS)‑mediated signaling through Τoll-like receptor 4 (TLR4) in HSCs has been identified as a key event in liver fibrosis, and as the molecular link between inflammation and liver fibrosis. In this study, we investigated the effects of caffeic acid phenethyl ester (CAPE), one of the main medicinal components of propolis, on the pro‑inflammatory and fibrogenic phenotypes of LPS-stimulated HSCs. HSCs from rats were isolated and cultured in Dulbecco's modified Eagle's medium (DMEM). Following treatment with LPS, HSCs showed a strong pro-inflammatory phenotype with an upregulation of pro-inflammatory mediators, and a fibrogenic phenotype with enhanced collagen synthesis, mediated by transforming growth factor-β1 (TGF‑β1). CAPE significantly and dose-dependently reduced LPS-induced nitrite production, as well as the transcription and protein synthesis of monocyte chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6) and inducible nitric oxide synthase (iNOS), as determined by quantitative reverse transcription-polymerase chain reaction (qRT-PCR), western blotting and enzyme-linked immunosorbent assays (ELISA). CAPE further reduced the TGF-β1‑induced transcription and translation (protein synthesis) of the gene coding for collagen type I α1 (col1A1), in LPS-stimulated HSCs. Following LPS stimulation, the phosphorylation of the nuclear factor-κB (NF-κB) inhibitor IκBα and consequently, the nuclear translocation of NF-κB, were markedly increased in the HSCs, and these changes were reversed by pre-treatment with CAPE. In conclusion, CAPE attenuates the pro-inflammatory phenotype of LPS-stimulated HSCs, as well as the LPS-induced sensitization of HSCs to fibrogenic cytokines by inhibiting NF-κB signaling. Our results provide new insight into the treatment of hepatic fibrosis through regulation of the TLR4 signaling pathway.

View Figures

View References

1	Friedman SL: Stellate cells: a moving target in hepatic fibrogenesis. Hepatology. 40:1041–1043. 2004. View Article : Google Scholar : PubMed/NCBI
2	Shaker ME, Ghani A, Shiha GE, Ibrahim TM and Mehal WZ: Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases. Biochim Biophys Acta. 1833:1992–2003. 2013. View Article : Google Scholar : PubMed/NCBI
3	Priya S and Sudhakaran PR: Cell survival, activation and apoptosis of hepatic stellate cells: modulation by extracellular matrix proteins. Hepatol Res. 38:1221–1232. 2008.PubMed/NCBI
4	Tacke F and Weiskirchen R: Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques. Expert Rev Gastroenterol Hepatol. 6:67–80. 2012. View Article : Google Scholar : PubMed/NCBI
5	Soares JB, Pimentel-Nunes P, Roncon-Albuquerque R and Leite-Moreira A: The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases. Hepatol Int. 4:659–672. 2010. View Article : Google Scholar : PubMed/NCBI
6	Seki E, De Minicis S, Osterreicher CH, et al: TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med. 13:1324–1332. 2007. View Article : Google Scholar : PubMed/NCBI
7	Yan X, Lin Z, Chen F, et al: Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling. J Biol Chem. 284:30097–30104. 2009. View Article : Google Scholar : PubMed/NCBI
8	Trebicka J, Krag A, Gansweid S, et al: Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt. Eur J Gastroenterol Hepatol. 23:1218–1225. 2011. View Article : Google Scholar
9	Hanck C, Rossol S, Böcker U, Tokus M and Singer MV: Presence of plasma endotoxin is correlated with tumour necrosis factor receptor levels and disease activity in alcoholic cirrhosis. Alcohol Alcohol. 33:606–608. 1998. View Article : Google Scholar : PubMed/NCBI
10	Zhu Q, Zou L, Jagavelu K, et al: Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice. J Hepatol. 56:893–899. 2012. View Article : Google Scholar : PubMed/NCBI
11	Bai T, Lian LH, Wu YL, Wan Y and Nan JX: Thymoquinone attenuates liver fibrosis via PI3K and TLR4 signaling pathways in activated hepatic stellate cells. Int Immunopharmacol. 15:275–281. 2013. View Article : Google Scholar : PubMed/NCBI
12	Pradere JP, Troeger JS, Dapito DH, Mencin AA and Schwabe RF: Toll-like receptor 4 and hepatic fibrogenesis. Semin Liver Dis. 30:232–244. 2010. View Article : Google Scholar : PubMed/NCBI
13	Luedde T and Trautwein C: A molecular link between inflammation and fibrogenesis: the bacterial microflora influences hepatic fibrosis via toll-like receptor 4-dependent modification of transforming growth factor-beta signaling in hepatic stellate cells. Hepatology. 47:1089–1091. 2008. View Article : Google Scholar
14	Akira S, Uematsu S and Takeuchi O: Pathogen recognition and innate immunity. Cell. 124:783–801. 2006. View Article : Google Scholar
15	Isayama F, Hines IN, Kremer M, et al: LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice. Am J Physiol Gastrointest Liver Physiol. 290:G1318–G1328. 2006. View Article : Google Scholar : PubMed/NCBI
16	Lotfy M, Badra G, Burham W and Alenzi FQ: Combined use of honey, bee propolis and myrrh in healing a deep, infected wound in a patient with diabetes mellitus. Br J Biomed Sci. 63:171–173. 2006.PubMed/NCBI
17	Ansorge S, Reinhold D and Lendeckel U: Propolis and some of its constituents down-regulate DNA synthesis and inflammatory cytokine production but induce TGF-beta1 production of human immune cells. Z Naturforsch C. 58:580–589. 2003. View Article : Google Scholar : PubMed/NCBI
18	Wongmekiat O, Gomonchareonsiri S and Thamprasert K: Caffeic acid phenethyl ester protects against oxidative stress-related renal dysfunction in rats treated with cyclosporin A. Fundam Clin Pharmacol. 25:619–626. 2011. View Article : Google Scholar : PubMed/NCBI
19	Oktar S, Yönden Z, Aydin M, Ilhan S, Alcin E and Ozturk OH: Protective effects of caffeic acid phenethyl ester on iron-induced liver damage in rats. J Physiol Biochem. 65:339–344. 2009. View Article : Google Scholar : PubMed/NCBI
20	Toyoda T, Tsukamoto T, Takasu S, et al: Anti-inflammatory effects of caffeic acid phenethyl ester (CAPE), a nuclear factor-kappaB inhibitor, on Helicobacter pylori-induced gastritis in Mongolian gerbils. Int J Cancer. 125:1786–1795. 2009. View Article : Google Scholar : PubMed/NCBI
21	Ozturk G, Ginis Z, Akyol S, Erden G, Gurel A and Akyol O: The anticancer mechanism of caffeic acid phenethyl ester (CAPE): review of melanomas, lung and prostate cancers. Eur Rev Med Pharmacol Sci. 16:2064–2068. 2012.PubMed/NCBI
22	Lee Y, Shin DH, Kim JH, et al: Caffeic acid phenethyl ester-mediated Nrf2 activation and IkappaB kinase inhibition are involved in NFkappaB inhibitory effect: structural analysis for NFkappaB inhibition. Eur J Pharmacol. 643:21–28. 2010. View Article : Google Scholar : PubMed/NCBI
23	Natarajan K, Singh S, Burke TR Jr, Grunberger D and Aggarwal BB: Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci USA. 93:9090–9095. 1996. View Article : Google Scholar : PubMed/NCBI
24	Abdel-Latif MM, Windle HJ, Homasany BS, Sabra K and Kelleher D: Caffeic acid phenethyl ester modulates Helicobacter pylori-induced nuclear factor-kappa B and activator protein-1 expression in gastric epithelial cells. Br J Pharmacol. 146:1139–1147. 2005.PubMed/NCBI
25	Ramm GA: Isolation and culture of rat hepatic stellate cells. J Gastroenterol Hepatol. 13:846–851. 1998. View Article : Google Scholar : PubMed/NCBI
26	Weiskirchen R and Gressner AM: Isolation and culture of hepatic stellate cells. Methods Mol Med. 117:99–113. 2005.PubMed/NCBI
27	Robertson DA, Hughes GA and Lyles GA: Expression of inducible nitric oxide synthase in cultured smooth muscle cells from rat mesenteric lymphatic vessels. Microcirculation. 11:503–515. 2004. View Article : Google Scholar : PubMed/NCBI
28	Cikos S, Bukovska A and Koppel J: Relative quantification of mRNA: comparison of methods currently used for real-time PCR data analysis. BMC Mol Biol. 8:1132007. View Article : Google Scholar : PubMed/NCBI
29	Simone RE, Russo M, Catalano A, et al: Lycopene inhibits NF-κB-mediated IL-8 expression and changes redox and PPARγ signalling in cigarette smoke-stimulated macrophages. PLoS One. 6:e196522011.
30	Bhoopathi P, Chetty C, Kunigal S, Vanamala SK, Rao JS and Lakka SS: Blockade of tumor growth due to matrix metalloproteinase-9 inhibition is mediated by sequential activation of beta1-integrin, ERK, and NF-kappaB. J Biol Chem. 283:1545–1552. 2008. View Article : Google Scholar : PubMed/NCBI
31	Li H, Zheng HW, Chen H, et al: Hepatitis B virus particles preferably induce Kupffer cells to produce TGF-beta1 over pro-inflammatory cytokines. Dig Liver Dis. 44:328–333. 2012. View Article : Google Scholar : PubMed/NCBI
32	Schnabl B, Brandl K, Fink M, et al: A TLR4/MD2 fusion protein inhibits LPS-induced pro-inflammatory signaling in hepatic stellate cells. Biochem Biophys Res Commun. 375:210–214. 2008. View Article : Google Scholar : PubMed/NCBI
33	Bataller R and Brenner DA: Liver fibrosis. J Clin Invest. 115:209–218. 2005. View Article : Google Scholar
34	Frasinariu OE, Ceccarelli S, Alisi A, Moraru E and Nobili V: Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies. Dig Liver Dis. 45:543–551. 2013. View Article : Google Scholar : PubMed/NCBI
35	Gäbele E, Dostert K, Hofmann C, et al: DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. J Hepatol. 55:1391–1399. 2011.PubMed/NCBI
36	Guo J and Friedman SL: Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis. Fibrogenesis Tissue Repair. 3:212010. View Article : Google Scholar : PubMed/NCBI
37	Guo J, Loke J, Zheng F, et al: Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses. Hepatology. 49:960–968. 2009. View Article : Google Scholar : PubMed/NCBI
38	Brun P, Castagliuolo I, Pinzani M, Palu G and Martines D: Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 289:G571–G578. 2005. View Article : Google Scholar : PubMed/NCBI
39	Seki E, De Minicis S, Gwak GY, et al: CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest. 119:1858–1870. 2009.PubMed/NCBI
40	Seki E, de Minicis S, Inokuchi S, et al: CCR2 promotes hepatic fibrosis in mice. Hepatology. 50:185–197. 2009. View Article : Google Scholar : PubMed/NCBI
41	Borrelli F, Izzo AA, Di Carlo G, et al: Effect of a propolis extract and caffeic acid phenethyl ester on formation of aberrant crypt foci and tumors in the rat colon. Fitoterapia. 73(Suppl 1): S38–S43. 2002. View Article : Google Scholar : PubMed/NCBI
42	Juman S, Yasui N, Ikeda K, et al: Caffeic acid phenethyl ester suppresses the production of pro-inflammatory cytokines in hypertrophic adipocytes through lipopolysaccharide-stimulated macrophages. Biol Pharm Bull. 35:1941–1946. 2012. View Article : Google Scholar
43	Kawelke N, Vasel M, Sens C, Au A, Dooley S and Nakchbandi IA: Fibronectin protects from excessive liver fibrosis by modulating the availability of and responsiveness of stellate cells to active TGF-beta. PLoS One. 6:e281812011. View Article : Google Scholar : PubMed/NCBI
44	Novotny NM, Markel TA, Crisostomo PR and Meldrum DR: Differential IL-6 and VEGF secretion in adult and neonatal mesenchymal stem cells: role of NFkB. Cytokine. 43:215–219. 2008. View Article : Google Scholar : PubMed/NCBI
45	Wang Y, Rangan GK, Goodwin B, Tay YC and Harris DC: Lipopolysaccharide-induced MCP-1 gene expression in rat tubular epithelial cells is nuclear factor-kappaB dependent. Kidney Int. 57:2011–2022. 2000. View Article : Google Scholar : PubMed/NCBI
46	Karin M and Ben-Neriah Y: Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol. 18:621–663. 2000.PubMed/NCBI
47	Karin M and Delhase M: The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol. 12:85–98. 2000. View Article : Google Scholar : PubMed/NCBI
48	Ribeiro PS, Cortez-Pinto H, Solá S, et al: Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol. 99:1708–1717. 2004. View Article : Google Scholar